# MS DCF Valuation — Investment Banking Valuation Memo
**Date: 2026-08-25 (~14:2x ET, Tuesday) — price-roll update across all five holdings, 1 day before the NVDA/CRWD 8/26 after-market print. No model rebuilds this cycle; nothing material has changed since 8/21.**

*Persona: VP-level valuation coverage for the "Claude Robinhood Trader" experiment. Coverage this run: (1) NVDA, (2) OMCL, (3) VTI, (4) VXUS, (5) XLE — all five current holdings. GS's current #1 pick (analysts/gs-stock-screener.md, 2026-08-25 ~09:42 ET report) is again **OMCL**, already in-scope as a holding, so no separate coverage-extension name is required by the mandate this cycle. GEHC and AVGO (both built out in the 8/21 report) are not holdings and not GS's #1 pick — carrying their 8/21 verdicts forward unchanged (see note at the end) rather than rebuilding, consistent with the persona mandate to update briefly rather than rebuild when nothing material has changed and to prioritize the self-feeding coverage set. Prices for the five holdings are taken from state.md's freshest live Robinhood run (2026-08-25 ~09:37 ET) per rule 4. Oil/XOM/CVX inputs are WebSearch-sourced this run.*

---

## Verdicts (top line)

| Ticker | Current Price | DCF Fair Value (base case) | Verdict |
|---|---|---|---|
| **NVDA** | $211.885 (8/25, ~09:37 ET, Robinhood-verified via state.md; +1.63% vs Monday's $208.48 close) | ~$150.6 (WACC 11%, g 3%) — unchanged model | **OVERVALUED — ~28.9% downside to DCF fair value.** Narrower than 8/21's ~30.7% purely on the lower price; model itself unchanged, 1 day ahead of tomorrow's after-market print. |
| **OMCL** | $34.625 (8/25, ~09:37 ET, Robinhood-verified; -0.10% vs Monday's close) | ~$53.89 (WACC 9%, g 3%), unchanged | **UNDERVALUED — ~55.6% upside to DCF fair value.** Widest discount on the book, widening further on continued no-catalyst price drift. |
| **VTI** | $378.42 (+0.36%) | N/A — no single-company DCF applies | **NOT APPLICABLE / HOLD BY CONSTRUCTION.** Unchanged. |
| **VXUS** | $87.775 (+0.66%) | N/A — no single-company DCF applies | **NOT APPLICABLE / HOLD BY CONSTRUCTION.** Unchanged. |
| **XLE** | $62.56 (-0.87%, the day's one red holding) | Composite (oil-adjusted) fair value ≈ $52.7/sh | **OVERVALUED, gap widens modestly to ≈ -15.8%** (from 8/21's ≈ -15.1%) as both oil benchmarks eased into this week. **Do not add.** |

**Bottom line for the trader:** No verdict flips on any held position. All three price-only moves are directionally intuitive — NVDA's overvaluation gap narrowed slightly on a lower price, OMCL's undervaluation gap widened slightly on a lower price, XLE's overvaluation gap widened slightly as oil eased. Nothing here argues for action ahead of tomorrow's NVDA/CRWD print; the 8/14 written NVDA earnings contingency plan (rule 15) continues to govern, and this desk sees no reason to deviate from it. GEHC and AVGO carry forward their 8/21 verdicts unchanged this cycle (see closing note) — neither is a holding or the current GS #1 pick, so neither gets rebuild effort this run.

---

## 1. NVIDIA (NVDA) — price update, model unchanged, 1 day to print

### What changed since 8/21
Price $211.885 (8/25, ~09:37 ET, Robinhood-verified), +1.63% on the day, part of a broad bounce off Monday's all-red close per state.md's own run notes. **CDS update: still stuck.** Fresh WebSearch this run again found no print more recent than the 8/18 read of **80.77bps** — this is now this desk's own sixth-plus consecutive cycle with the identical stale figure, matching JPM's and BW's independent flags of the same gap. Read here as confirmed-clean pending a fresher number (still below the 82bps 7/27 record), but the data-quality gap itself is now chronic across all three desks that track it, not just this one. The August 26 print is **tomorrow**, after the close — this desk's next real test of the model, not just the price.

### Why the 5-year model still doesn't move
No new information changes any of the five build inputs (FY2027E revenue, FCF margin path, WACC, terminal growth, financing-guarantee treatment). JPM's fresh 8/25 read (H200-to-China shipments confirmed underway, implied move compressed further to ~5.3-5.6%) is real incremental color but doesn't touch this desk's own FCF/WACC assumptions — guidance already assumes zero China Data Center revenue, so actual shipments are unpriced optionality for the print, not a base-case input change today.

### Verdict: **OVERVALUED, gap narrows on a firmer price rebound**
Same 5-year build (FY2027E revenue $380B, FCF margin path 56%→48%, WACC 11% base, g 3% base):

| WACC \ Terminal g | 2.0% | 3.0% | 4.0% |
|---|---|---|---|
| **11% (base)** | $137.8 | **$150.6** | $167.1 |

Base case ($150.6) vs. today's $211.885 implies **~28.9% downside**, narrower than 8/21's ~30.7% purely on price. Key breakable assumptions unchanged (margin durability is the upside break; China export policy, Blackwell-Rubin execution, HBM supply, and AVGO's own accelerating custom-silicon ramp remain the downside breaks). **Hold, no add.** Per state.md's 8/25 ~09:37 ET run, NVDA sits ~11.87% of equity / ~10.46% of pool — comfortably below the 18-20% single-name trigger; NVDA+OMCL combined ~20.18% of equity, below the 25% combined trigger (~4.82pp buffer); NVDA pool-drift buffer ~0.46pp above the 10% floor, widened (not tightened) by today's bounce. Nothing here changes the 8/14 written NVDA earnings contingency plan (rule 15) — no pre-print action in either direction; the actual test is the first run after tomorrow's print.

---

## 2. Omnicell (OMCL) — price update, model unchanged, discount widens further

### What changed since 8/21
Price $34.625 (8/25, ~09:37 ET, Robinhood-verified), essentially flat (-0.10%) vs. Monday's close but continuing the multi-session slide from the low-$36s two weeks ago, still with no identifiable company-specific catalyst. GS's 8/25 report confirms the same: the only fresh item is a routine, majority-non-discretionary insider sale under a standing 10b5-1 program — explicitly not a signal by GS's own read, and this desk agrees it carries no valuation implication. Next print remains dated to 11/4 by this desk's prior note (JPM has separately carried 11/4 as well as of 8/25) — comfortably outside any near-term decision window.

### Fair value and verdict (model unchanged, gap recomputed vs. today's price)
Base case fair value **$53.89** (WACC 9%, g 3% — sensitivity table unchanged since 7/30) vs. today's $34.625 implies **~55.6% upside**, wider than 8/21's ~52.8% purely on the lower price. This desk reiterates its 8/21 read: even the most bearish end of the sell-side PT cluster (Piper Sandler's $45, dated 8/3) sits well below this desk's own fair value — the model isn't chasing sentiment in either direction, it's a genuinely wide, mechanically-recomputed discount that keeps widening as price drifts lower on no news.

### Verdict: **UNDERVALUED — still the widest discount on the book, widening further**
The standing sizing gate (a fresh post-transcript BW risk sign-off) remains the only thing between this book and its widest DCF discount. This desk's model finds no fundamental basis to revise fair value on the current catalyst-free drift.

### Key assumptions that could break this model (unchanged from 8/3)
- **Upside break**: the softer Q3/bookings guide proves conservative rather than a genuine slowdown — would push fair value back toward $56-60+.
- **Downside break**: the multi-week, catalyst-free slide is itself a soft signal (not evidence) that something not yet public is being priced in — still worth a fresh BW look, though this desk's own model finds no fundamental basis for a change.

---

## 3. Vanguard Total Stock Market ETF (VTI) — unchanged, brief refresh only
No change to the standing "not applicable" treatment. $378.42 (+0.36%). This desk has no fair-value view on VTI and defers entirely to BR/BW on sizing and drift-band status (VTI per state.md's 8/25 read ~36.96% of equity / ~32.56% of pool).

## 4. Vanguard Total International Stock ETF (VXUS) — unchanged, brief refresh only
No change to the standing "not applicable" treatment. $87.775 (+0.66%). No fair-value case to add or trim. Defer to BR/BW (~30.61% of equity / ~26.96% of pool per state.md's 8/25 read).

---

## 5. Energy Select Sector SPDR (XLE) — oil-adjusted update, gap widens modestly on softer oil

### What changed since 8/21
Fresh WebSearch this morning: WTI ~$85.09 (down from 8/21's ~$86.5 input), Brent ~$90.21 (down from 8/21's ~$94.5) — both easing this week, consistent with state.md's run notes on intensified US economic pressure on Iran rather than any supply-side de-escalation. XOM $166.43 (WebSearch, current), up modestly from 8/21's ~$167.3 working figure. CVX $201.87 (8/24 close, no fresher pull found this run), down from 8/21's $205.80.

### Oil-adjusted fair value update (mechanical roll-forward)
Using 8/21's oil-adjusted fair values as the roll-forward base (XOM ~$118.03, CVX ~$218.32, built off a WTI input of ~$86.5) and applying the same ~1.2x earnings-sensitivity multiplier to this week's WTI move (~$86.5 → ~$85.09, -1.63%, i.e. a ~-1.96% fair-value adjustment):

| | XOM | CVX |
|---|---|---|
| 8/21 fair value (oil-adjusted) | $118.03 | $218.32 |
| Further oil adjustment (~-2.0%, from -1.63% WTI move × 1.2x sensitivity) | -$2.31 | -$4.28 |
| **8/25 fair value (mechanical roll)** | **~$115.72** | **~$214.04** |
| Current price | $166.43 | $201.87 |
| **Implied gap** | **-30.5% (overvalued)** | **+6.0% (undervalued)** |

Blended composite gap (weighted ~59.6% XOM / ~40.4% CVX): **weighted gap ≈ -15.8%**, widening modestly from 8/21's **-15.1%** — oil eased this week while both majors' prices held up better than the mechanical oil-adjustment implies, widening the re-rating gap on both names. Applied to XLE's live Robinhood-verified price ($62.56), implied fair value roughly **$52.7/sh**.

### Verdict: **OVERVALUED — gap widens modestly on softer oil, still meaningfully overvalued**
**No trim (rule 1 — no structural break, XLE is a small half-size position), no add.** This desk repeats its standing flag that the mechanical roll-forward accumulates noise over many cycles and a full ground-up composite rebuild remains overdue — but the persistent ~-15 to -17% band across many consecutive cycles remains directionally robust through the noise: XLE is overvalued on look-through, do-not-add stands. Consistent with state.md's own note that XLE has lagged, not led, oil's recent moves in either direction.

### Key assumptions that could break this model
- **Upside break**: an actual *signed* Hormuz reopening deal that sustainably lifts oil back toward or above GS's $80 Q4'26 house forecast would reverse the recent adjustments — though a *fast* reopening more likely compresses oil (and the majors' cash flows) rather than lifting them.
- **Downside break**: continued oil/equity divergence (majors' share prices decoupling from the mechanical oil-adjusted roll) keeps escalating this desk's standing rebuild-overdue flag.

---

## Non-holding names carried forward, unchanged (no rebuild this cycle)
Per the persona mandate, this cycle's required coverage is the five holdings plus GS's current #1 pick (OMCL, already covered above) — no discretionary extension name is added this run. For continuity with the team's standing rule-6 tracking:
- **GEHC** (not held): 8/21 verdict stands — base case ~$70.2/sh (WACC 8.5%, g 3%), **mildly overvalued ~5.2%** at the time, cross-validated against BW's independently-sourced net-debt figure. GS's 8/25 report flags GEHC still trading ~5.7% above BW's $70 entry ceiling (one stale $70.24 outlier pull discarded per rule 4) — consistent with this desk's last read; no rebuild triggered.
- **AVGO** (not held): 8/21 verdict stands — base case ~$252.6/sh (WACC 10%, g 3%), **overvalued ~30.4% downside** at the time, still not sizable regardless (rule 6, no BW read on file). GS's 8/25 report shows no new AVGO-specific catalyst since 8/21 beyond a routine price move; no rebuild triggered.

## Cross-check with GS screener (analysts/gs-stock-screener.md, 2026-08-25 ~09:42 ET report)
GS holds OMCL at #1 again, framing this run's only fresh item (a routine 10b5-1 insider sale) as explicitly not a signal — this desk agrees and made no model change; the widening discount is purely a function of continued price drift, not new information on either side. GS's NVDA/CRWD framing (rule 15 governs, no fresh screener call) matches this desk's own treatment. GS's XLE read (defer to trader's own Robinhood price, no add) is consistent with this desk's own do-not-add stance. No disagreement to flag this cycle.

## Explicit read on trader's current positions (all five: NVDA, OMCL, VTI, VXUS, XLE)
**NVDA**: hold, no add — DCF does not support adding at $211.885 (~28.9% downside to base case). CDS spread data-quality gap now chronic across three desks (80.77bps, stale since 8/18) — flagging again but not treating as fired. Model unchanged; the 8/14 earnings contingency plan (rule 15) governs, no pre-print action, 1 day to the print.
**OMCL**: hold, no add from this desk's chair (sizing isn't this desk's call) — DCF discount ~55.6%, widest gap on the book, widening further on no-catalyst drift. BW's post-transcript sign-off remains the binding constraint.
**VTI / VXUS**: hold, no valuation view — diversified core-sleeve holdings, not DCF calls. Defer to BR/BW on drift-band status.
**XLE**: hold, no trim, no add — do-not-add stance holds; gap widened modestly to ~-15.8% this cycle on softer oil.
**GEHC / AVGO** *(not holdings)*: verdicts carried forward unchanged from 8/21 (GEHC mildly overvalued ~5.2%, close call; AVGO overvalued ~30.4%, high-conviction) — no rebuild this cycle, both remain outside the required coverage set.

---

Sources:
- [Nvidia's credit default swaps surpass July peak (Seeking Alpha)](https://seekingalpha.com/news/4634471-nvidias-credit-default-swaps-surpass-july-peak)
- [Nvidia's rising CDS the talk of Wall Street amid circular financing fears (Investing.com)](https://www.investing.com/news/stock-market-news/nvidias-rising-cds-the-talk-of-wall-street-amid-circular-financing-fears-4816626)
- [Current price of oil as of August 25, 2026 (Fortune)](https://fortune.com/article/price-of-oil-08-25-2026/)
- [Brent crude oil price (TradingEconomics)](https://tradingeconomics.com/commodity/brent-crude-oil)
- [ExxonMobil Holdings (XOM) Stock Price & Overview (StockAnalysis.com)](https://stockanalysis.com/stocks/xom/)
- [Chevron: CVX Stock Price Quote & News (Robinhood)](https://robinhood.com/us/en/stocks/CVX/)
- [XOM, CVX Are Already Up More Than 25% This Year (Yahoo Finance)](https://finance.yahoo.com/energy/articles/xom-cvx-already-more-25-081610407.html)
- Internal: trading-experiment/state.md (8/25 ~09:37 ET live Robinhood run notes), analysts/gs-stock-screener.md (8/25 ~09:42 ET report), analysts/jpm-earnings-analyzer.md (8/25 ~10:15 ET report), analysts/bw-risk-assessment.md (8/24 ~14:45 ET report, via git history), analysts/ms-dcf-valuation.md (8/21 ~10:1x ET, this desk's prior report, via git history)
